Predictors of the "Crosstalk" Phenomenon During Cryoballoon Ablation in Patients with Atrial Fibrillation.


Journal

International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240

Informations de publication

Date de publication:
30 Mar 2021
Historique:
pubmed: 19 3 2021
medline: 7 4 2021
entrez: 18 3 2021
Statut: ppublish

Résumé

Second-generation cryoballoon (CB) ablation is effective in achieving pulmonary vein (PV) isolation (PVI) in atrial fibrillation (AF) patients. The "crosstalk" (CST) phenomenon has been reported to reduce unnecessary applications during CB ablation. Nevertheless, it is unclear under what conditions the CST phenomenon occurs.To seek the predictors of the CST phenomenon during CB-guided PVI, CST phenomenon in achieving ipsilateral superior PVI during inferior PV ablation was analyzed in AF patients who underwent de novo ablation using CB. CB occlusion status and nadir balloon temperature (NT) were compared in these patients, and all ablated superior PVs were categorized into three groups according to the necessity of the touch up ablation and effectiveness of the phenomenon.Of 1082 superior PVs, 16, 40, and 1026 were classified into the CST success, CST failure, and control groups (unnecessary CST), respectively. The proportion of superior PVs ablated with complete occlusion using the CB was significantly higher in the CST success group than in the other two groups. The proportion of superior PVs ablated with NT ≤ -46°C was higher in the CST success group than in the CST failure group. The CST phenomenon was always observed if CB ablation of the superior PVs was performed with both complete occlusion and NT ≤ -46°C and was almost always ineffective if it did not meet these two criteria (sensitivity, 100%; specificity, 93%).Successful CST ablation was highly predicted if complete PV occlusion and NT ≤ -46°C during CB ablation of the superior PVs were achieved.

Identifiants

pubmed: 33731538
doi: 10.1536/ihj.20-690
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-328

Auteurs

Tatsuhiko Hirao (T)

Heart Center, Yokohama-City Bay Red Cross Hospital.
Department of Cardiovascular Medicine, Tokyo Medical and Dental University.

Yasuteru Yamauchi (Y)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Rena Nakamura (R)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Takatoshi Shigeta (T)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Hiroshi Yoshida (H)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Shinichi Tachibana (S)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Atsuhito Oda (A)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Aki Ito (A)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Mitsutoshi Asano (M)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Hidetoshi Suzuki (H)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Tsukasa Shimura (T)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Manabu Kurabayashi (M)

Heart Center, Yokohama-City Bay Red Cross Hospital.

Masahiko Goya (M)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University.

Kaoru Okishige (K)

Heart Center, Yokohama-City Bay Red Cross Hospital.
Yokohama Minato Heart Clinic.

Tetsuo Sasano (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH